ViroPharma
USD (2005) | |
Number of employees | 232[1] |
---|---|
Website | www.viropharma.com |
ViroPharma Incorporated was a
The company had strategic relationships with
History
ViroPharma Incorporated was founded in 1994 by Claude H. Nash (Chief Executive Officer), Mark A. McKinlay (Vice President, Research & Development), Marc S. Collett (Vice President, Discovery Research), Johanna A. Griffin (Vice President, Business Development), and Guy D. Diana (Vice President, Chemistry Research.) None of the founders are still with the company.
In November 2014,
Products
Marketed products
Pipeline
In March 2006, the company announced that a
ViroPharma conducted a
Failed products
In 2001, ViroPharma submitted a New Drug Application of pleconaril to the FDA for the common cold.[10] On 2002-03-19, the FDA Antiviral Advisory Committee recommended that the company had failed to show adequate safety, and the FDA subsequently issued a not-approvable letter.[11]
In November 2004, ViroPharma licensed pleconaril to Schering-Plough,[12] who are developing an intranasal formulation for the common cold and asthma exacerbations. (Schering-Plough Development Pipeline). In August 2006, Schering-Plough started a Phase II clinical trial.
References
- ^ "Symbol Lookup from Yahoo Finance". finance.yahoo.com.
- ^ "Shire acquires ViroPharma for $4.2bn". Financier Worldwide. Retrieved 23 April 2020.
- ISSN 1937-8661. Retrieved 26 September 2008.
- ^ "Lev Pharmaceuticals Investor Relations". Lev Pharmaceuticals. Retrieved 8 April 2009.
- ^ Kitamura, Makiko (11 November 2013). "Shire Buys ViroPharma for $4.2 Billion to Add Orphan Drug". Bloomberg.
- ^ Pollack, Andrew (9 November 2005). "Crucial Antibiotic Rescues Biotech Maker's Finances". The New York Times. Retrieved 20 September 2007.
- ^ "FDA GRANTS FAST-TRACK STATUS FOR VIROPHARMA'S MARIBAVIR". www.fdanews.com. Retrieved 19 August 2020.
- ^ "FDA grants fast track status for ViroPharma's Maribavir | health.am". Retrieved 19 August 2020.
- ^ ViroPharma:Maribavir Phase III Study Missed Goal;Shares Plunge Archived 12 February 2009 at the Wayback Machine, CNN Money, 9 February 2009
- ^ Freundlich, Naomi (3 February 2002). "On the Trail of a Cure For the Common Cold". The New York Times. Retrieved 20 September 2007.
- ^ Pollack, Andrew (20 March 2002). "F.D.A. Panel Opposes Drug Meant to Treat Cause of Colds". The New York Times. Retrieved 20 September 2007.
- ^ "Picornaviruses and Schering-Plough" (PDF). Retrieved 23 December 2023.
Further references
- The Long Road Ahead for ViroPharma Motley Fool 29 September 2006